Mutual funds holding both Jubilant Pharmova and Zim Laboratories

Comparing mutual fund co-ownership helps identify hidden asset concentration. Our reverse lookup database shows that 1 mutual funds hold active equity positions in both Jubilant Pharmova and Zim Laboratories. The scheme with the highest combined exposure is Tata India Pharma & Healthcare Fund (Tata MF), which holds a 0.25% stake in Jubilant Pharmova and a 0.49% stake in Zim Laboratories, amounting to a combined conviction weight of 0.74%.

When multiple mutual funds in your portfolio double-up on the same stock pairs, it limits your diversification benefits. If you also hold either of these companies directly in your demat account, your aggregate exposure is amplified. This co-ownership pattern is standard among index-tracking products but represents active, concentrated strategies in equity schemes.